4
Changes in Ownership
Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-25-052413
Executive Vice President sold 131,856 shares at $11.92 ($1,571,724)
- Executive Vice President acquired 131,856 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shah Nikita Executive Vice President | 2025-11-12 | Option exercise | +36,331 | $2.75 | $99,910 | 182,734 | D |
| Shah Nikita Executive Vice President | 2025-11-12 | Option exercise | +95,525 | $2.75 | $262,694 | 278,259 | D |
| Shah Nikita Executive Vice President | 2025-11-12 | Sale | −131,856 | $11.92 | $1,571,724 | 146,403 | D |
| Derivatives | |||||||
| Shah Nikita Executive Vice President | 2025-11-12 | Option exercise · Stock Option (Right to Buy) | −36,331 | 0 | D | ||
| Shah Nikita Executive Vice President | 2025-11-12 | Option exercise · Stock Option (Right to Buy) | −95,525 | 0 | D | ||
| Open-market sales · 131,856 sh · avg $11.92 · $1,571,724 | |||||||
Loading xslF345X05/wk-form4_1763158428.xml…